{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:59:09Z","timestamp":1780747149038,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Schistosomiasis is a neglected tropical disease associated with significant morbidity and mortality. Treatment with praziquantel; the sole current medication for human schistosomiasis, is associated with incomplete resolution of\n                    <jats:italic>Schistosoma mansoni<\/jats:italic>\n                    -induced liver pathology. Therefore, there is a crucial need to introduce adjuvant agents that can mitigate the pathological events. This study aims to assess the hepatoprotective effects of the oral anti-diabetic drug dapagliflozin, alone and in combination with praziquantel. In the present research, combined dapagliflozin and praziquantel therapy caused significant decrease in adult worm burden and hepatic egg load, significant increase in the percent of mature and dead eggs and significant reduction in the percent of immature eggs in the small intestine, significant increase in hepatic levels of reduced glutathione and nitric oxide, significant attenuation of histopathological changes, and significant reduction in granuloma count and diameter. Additionally, immunohistochemical study of cleaved-caspase 3 revealed increased expression, compared to the untreated group. Our findings provide insight into dapagliflozin use as an advantageous adjuvant to praziquantel in alleviating schistosomal liver pathology. Future studies are needed to explore other pathways responsible for the hepatoprotective effects of dapagliflozin against\n                    <jats:italic>Schistosoma-mansoni<\/jats:italic>\n                    -induced liver fibrosis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-55860-8","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:44:18Z","timestamp":1780739058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective efficacy of dapagliflozin against schistosomiasis mansoni-induced liver pathology: an in vivo study"],"prefix":"10.1038","volume":"16","author":[{"given":"Mona K.","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokia","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma H.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Alhusseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"55860_CR1","doi-asserted-by":"publisher","first-page":"107504","DOI":"10.1016\/j.actatropica.2024.107504","volume":"261","author":"Q Li","year":"2025","unstructured":"Li, Q. al. Global trends of schistosomiasis burden from 1990 to 2021 across 204 countries and territories: Findings from GBD 2021 study. Acta Trop. 261, 107504 (2025).","journal-title":"Acta Trop."},{"key":"55860_CR2","doi-asserted-by":"publisher","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya, P., Chouhan, K., Weiskirchen, S. & Weiskirchen, R. Cellular mechanisms of liver fibrosis. Front. Pharmacol. 12, 671640 (2021).","journal-title":"Front. Pharmacol."},{"key":"55860_CR3","doi-asserted-by":"publisher","first-page":"1035765","DOI":"10.3389\/fcimb.2022.1035765","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Zhang, L., Liang, Y. & Lu, L. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis. Front. Cell. Infect. Microbiol. 12, 1035765 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"48","key":"55860_CR4","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang, C. Y., Yuan, W. G., He, P., Lei, J. H. & Wang, C. X. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J. Gastroenterol. 22 (48), 10512\u201310522 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"55860_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P. & Malik, A. B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20 (7), 1126\u20131167 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"55860_CR6","doi-asserted-by":"crossref","unstructured":"Pizzino, G. et al. Oxidative stress: Harms and benefits for human health. Oxid. Med. Cell. Longev. 8416763 (2017). (2017).","DOI":"10.1155\/2017\/8416763"},{"issue":"9","key":"55860_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman, H. J. & Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20 (9), 689\u2013709 (2021).","journal-title":"Nat. Rev. Drug Discov"},{"key":"55860_CR8","doi-asserted-by":"publisher","first-page":"806470","DOI":"10.3389\/fphar.2022.806470","volume":"13","author":"M Rudrapal","year":"2022","unstructured":"Rudrapal, M. et al. Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Front. Pharmacol. 13, 806470 (2022).","journal-title":"Front. Pharmacol."},{"key":"55860_CR9","doi-asserted-by":"publisher","first-page":"12572","DOI":"10.3390\/ijms232012572","volume":"23","author":"D Zhang","year":"2022","unstructured":"Zhang, D., Zhang, Y. & Sun, B. The molecular mechanisms of liver fibrosis and its potential therapy in application. Int. J. Mol. Sci. 23, 12572 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"55860_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/imm.13325","volume":"163","author":"MR Romo","year":"2021","unstructured":"Romo, M. R. Cell death as part of innate immunity: Cause or consequence? Immunology 163 (4), 399\u2013415 (2021).","journal-title":"Immunology"},{"issue":"4","key":"55860_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.cdd.4400989","volume":"9","author":"M Lamkanfi","year":"2002","unstructured":"Lamkanfi, M., Declercq, W., Kalai, M., Saelens, X. & Vandenabeele, P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell. Death Differ. 9 (4), 358\u2013361 (2002).","journal-title":"Cell. Death Differ."},{"issue":"4","key":"55860_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. & Apoptosis A review of programmed cell death. Toxicol. Pathol. 35 (4), 495\u2013516 (2007).","journal-title":"Toxicol. Pathol."},{"issue":"12","key":"55860_CR13","doi-asserted-by":"publisher","first-page":"e0168268","DOI":"10.1371\/journal.pone.0168268","volume":"11","author":"Y Wu","year":"2016","unstructured":"Wu, Y., Zhao, D., Zhuang, J., Zhang, F. & Chun Xu, C. Caspase\u20138 and caspase\u20139 functioned differently at different stages of the cyclic stretch-induced apoptosis in human periodontal ligament cells. PLoS One. 11 (12), e0168268 (2016).","journal-title":"PLoS One"},{"issue":"1","key":"55860_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41421-025-00791-3","volume":"11","author":"EK Nadendla","year":"2025","unstructured":"Nadendla, E. K., Tweedell, R. E., Kasof, G., Kanneganti, T. D. & Caspases Structural and molecular mechanisms and functions in cell death, innate immunity, and disease. Cell. Discov. 11 (1), 42 (2025).","journal-title":"Cell. Discov"},{"issue":"16","key":"55860_CR15","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3390\/ijerph16162965","volume":"16","author":"A Tentolouris","year":"2019","unstructured":"Tentolouris, A., Vlachakis, P., Tzeravini, E., Eleftheriadou, I. & Tentolouris, N. SGLT2 inhibitors: A review of their antidiabetic and cardioprotective effects. Int. J. Environ. Res. Public. Health. 16 (16), 2965 (2019).","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"42","key":"55860_CR16","doi-asserted-by":"publisher","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","volume":"295","author":"RJ Perry","year":"2020","unstructured":"Perry, R. J. & Shulman, G. I. Sodium-glucose cotransporter\u20132 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks. J. Biol. Chem. 295 (42), 14379\u201314390 (2020).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"55860_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","volume":"75","author":"TA Zelniker","year":"2020","unstructured":"Zelniker, T. A. & Braunwald, E. Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75 (4), 422\u2013434 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"55860_CR18","doi-asserted-by":"publisher","first-page":"10848","DOI":"10.1021\/acs.jmedchem.2c00867","volume":"65","author":"R Maccari","year":"2022","unstructured":"Maccari, R. & Ottan\u00e0, R. Sodium-glucose cotransporter inhibitors as antidiabetic drugs: Current development and future perspectives. J. Med. Chem. 65 (16), 10848\u201310881 (2022).","journal-title":"J. Med. Chem."},{"key":"55860_CR19","doi-asserted-by":"crossref","unstructured":"Hu, J., Teng, J., Hui, S. & Liang, L. SGLT\u20132 inhibitors as novel treatments of multiple organ fibrosis. Heliyon 10 (8), e29486 (2024).","DOI":"10.1016\/j.heliyon.2024.e29486"},{"key":"55860_CR20","doi-asserted-by":"publisher","first-page":"116991","DOI":"10.1016\/j.taap.2024.116991","volume":"489","author":"HA Hassan","year":"2024","unstructured":"Hassan, H. A. et al. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1\/AMPK\/PGC1\u03b1\/FoxO1 axis. Toxicol. Appl. Pharmacol. 489, 116991 (2024).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"55860_CR21","doi-asserted-by":"publisher","first-page":"E563","DOI":"10.1152\/ajpendo.00086.2017","volume":"313","author":"L Tang","year":"2017","unstructured":"Tang, L. et al. Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 313 (5), E563\u2013E576 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"55860_CR22","doi-asserted-by":"publisher","first-page":"120956","DOI":"10.1016\/j.lfs.2022.120956","volume":"308","author":"HH Shaaban","year":"2022","unstructured":"Shaaban, H. H. et al. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sci. 308, 120956 (2022).","journal-title":"Life Sci."},{"issue":"2","key":"55860_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic. Clin. Pharm. 7 (2), 27\u201331 (2016).","journal-title":"J. Basic. Clin. Pharm."},{"key":"55860_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00389899","volume":"52","author":"R G\u00f6nnert","year":"1977","unstructured":"G\u00f6nnert, R. & Andrews, P. Praziquantel, a new broad-spectrum antischistosomal agent. Z. Parasitenkund. 52, 129\u2013150 (1977).","journal-title":"Z. Parasitenkund"},{"issue":"4","key":"55860_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/S0031182000086248","volume":"55","author":"SR Smithers","year":"1965","unstructured":"Smithers, S. R. & Terry, R. J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55 (4), 695\u2013700 (1965).","journal-title":"Parasitology"},{"issue":"5","key":"55860_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"WN Arifin","year":"2017","unstructured":"Arifin, W. N. & Zahiruddin, W. M. Sample size calculation in animal studies using resource equation approach. Malays J. Med. Sci. 24 (5), 101\u2013105 (2017).","journal-title":"Malays J. Med. Sci."},{"issue":"1","key":"55860_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4269\/ajtmh.1968.17.38","volume":"17","author":"AW Cheever","year":"1968","unstructured":"Cheever, A. W. A quantitative post-mortem study of schistosomiasis mansoni in man. Am. J. Trop. Med. Hyg. 17 (1), 38\u201364 (1968).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"55860_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","volume":"11","author":"J Pellegrino","year":"1962","unstructured":"Pellegrino, J., Oliveira, C. A., Faria, J. & Cunha, A. S. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am. J. Trop. Med. Hyg. 11, 201\u2013215 (1962).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"55860_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","volume":"55","author":"S Tandra","year":"2011","unstructured":"Tandra, S. et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J. Hepatol. 55 (3), 654\u2013659 (2011).","journal-title":"J. Hepatol."},{"key":"55860_CR30","unstructured":"Suzuki, S. & Toledo-Pereyra, L. H. Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant. Proc. 25 (6), 3325\u20133327 (1993)."},{"issue":"5","key":"55860_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell, R. G. et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (5), 431\u2013435 (1981).","journal-title":"Hepatology"},{"key":"55860_CR32","unstructured":"Poo, J. L. et al. Semiquantitative histologic evaluation of the liver in patients after liver transplantation. Transplant. Proc. 24 (5), 1973\u20131975 (1992)."},{"issue":"6","key":"55860_CR33","first-page":"711","volume":"41","author":"F von Lichtenberg","year":"1962","unstructured":"von Lichtenberg, F. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am. J. Pathol. 41 (6), 711\u2013731 (1962).","journal-title":"Am. J. Pathol."},{"key":"55860_CR34","unstructured":"Suvarna, K. S., Layton, C. & Bancroft, J. D. Bancroft\u2019s Theory and Practice of Histological Techniques 8th edn (Elsevier, 2018)."},{"key":"55860_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijsu.2018.02.055","volume":"52","author":"KH Huang","year":"2018","unstructured":"Huang, K. H. et al. Caspase\u20133, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery. Int. J. Surg. 52, 258\u2013263 (2018).","journal-title":"Int. J. Surg."},{"issue":"1","key":"55860_CR36","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1038\/s41598-020-67514-4","volume":"10","author":"JK Nono","year":"2020","unstructured":"Nono, J. K. et al. Investigating the antifibrotic effect of the antiparasitic drug praziquantel in in vitro and in vivo preclinical models. Sci. Rep. 10 (1), 10638 (2020).","journal-title":"Sci. Rep."},{"issue":"5","key":"55860_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.33594\/000000178","volume":"53","author":"L Uthman","year":"2019","unstructured":"Uthman, L. et al. Empagliflozin and dapagliflozin reduce ROS generation and restore NO bioavailability in tumor necrosis factor \u03b1-stimulated human coronary arterial endothelial cells. Cell. Physiol. Biochem. 53 (5), 865\u2013886 (2019).","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"55860_CR38","doi-asserted-by":"publisher","first-page":"27082","DOI":"10.31083\/FBL27082","volume":"30","author":"T Li","year":"2025","unstructured":"Li, T., Luo, C. J., Yi, Z. Q. & Li, L. Dapagliflozin attenuates myocardial inflammation and apoptosis after coronary microembolization in rats by regulating the SIRT1\/NF-\u03baB signaling pathway. Front. Biosci. (Landmark Ed). 30 (3), 27082 (2025).","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"6","key":"55860_CR39","first-page":"111","volume":"65","author":"AR Shatat","year":"2022","unstructured":"Shatat, A. R., Ahmed, O. B. & Ali, G. A. M. Liver protection from acetaminophen hepatotoxicity using copper(I)-nicotinic acid complex. Egypt. J. Chem. 65 (6), 111\u2013120 (2022).","journal-title":"Egypt. J. Chem."},{"key":"55860_CR40","doi-asserted-by":"publisher","first-page":"175930","DOI":"10.1016\/j.ejphar.2023.175930","volume":"955","author":"X Han","year":"2023","unstructured":"Han, X. et al. Dapagliflozin ameliorates sepsis-induced heart injury by inhibiting cardiomyocyte apoptosis and electrical remodeling through the PI3K\/Akt pathway. Eur. J. Pharmacol. 955, 175930 (2023).","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"55860_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpara.2003.10.010","volume":"34","author":"SJ Davies","year":"2004","unstructured":"Davies, S. J. et al. Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int. J. Parasitol. 34 (1), 27\u201336 (2004).","journal-title":"Int. J. Parasitol."},{"key":"55860_CR42","doi-asserted-by":"publisher","first-page":"106730","DOI":"10.1016\/j.intimp.2020.106730","volume":"86","author":"M ElMahdy","year":"2020","unstructured":"ElMahdy, M., Kh., Helal, M. G. & Ebrahim, T. M. Potential anti-inflammatory effect of dapagliflozin in HCHF diet- induced fatty liver degeneration through inhibition of TNF-\u03b1, IL\u20131\u03b2, and IL\u201318 in rat liver. Int. Immunopharmacol. 86, 106730 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"55860_CR43","doi-asserted-by":"publisher","first-page":"1289663","DOI":"10.3389\/fcvm.2024.1289663","volume":"11","author":"V Quagliariello","year":"2024","unstructured":"Quagliariello, V. et al. Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-\u03baB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity. Front. Cardiovasc. Med. 11, 1289663 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"55860_CR44","doi-asserted-by":"publisher","first-page":"1205834","DOI":"10.3389\/fimmu.2023.1205834","volume":"14","author":"A Cai","year":"2023","unstructured":"Cai, A. et al. Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels. Front. Immunol. 14, 1205834 (2023).","journal-title":"Front. Immunol."},{"issue":"8","key":"55860_CR45","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1128\/iai.65.8.3457-3461.1997","volume":"65","author":"SA Rezende","year":"1997","unstructured":"Rezende, S. A. et al. Mice lacking the gamma interferon receptor have an impaired granulomatous reaction to Schistosoma mansoni infection. Infect. Immunol. 65 (8), 3457\u20133461 (1997).","journal-title":"Infect. Immunol."},{"issue":"2","key":"55860_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.47665\/tb.38.2.059","volume":"38","author":"WM Salama","year":"2021","unstructured":"Salama, W. M., El-Naggar, S. A., Harras, S. F. & El-Said, K. An adjuvant effect of metformin as an anti-fibrotic agent when administered with the anti-schistosomal praziquantel in Schistosoma mansoni infected mice. Trop. Biomed. 38 (2), 205\u2013213 (2021).","journal-title":"Trop. Biomed."},{"issue":"2","key":"55860_CR47","first-page":"117","volume":"14","author":"A Asta","year":"2024","unstructured":"Asta, A., Dahl, J., Bryant, D. & Ammar, H. An ancient disease hepatosplenic schistosomiasis. J. Community Hosp. Intern. Med. Perspect. 14 (2), 117\u2013119 (2024).","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"issue":"2","key":"55860_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4269\/ajtmh.2008.78.228","volume":"78","author":"N Berhe","year":"2008","unstructured":"Berhe, N., Myrvang, B. & Gundersen, S. G. Reversibility of schistosomal periportal thickening\/fibrosis after praziquantel therapy: A twenty-six month follow-up study in Ethiopia. Am. J. Trop. Med. Hyg. 78 (2), 228\u2013234 (2008).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"16","key":"55860_CR49","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.3390\/ijms26167729","volume":"26","author":"JH Choi","year":"2025","unstructured":"Choi, J. H. Histological and molecular evaluation of liver biopsies: A practical and updated review. Int. J. Mol. Sci. 26 (16), 7729 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"55860_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00436-025-08474-4","volume":"124","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Eggs of Schistosoma japonicum deposited in the spleen induce apoptosis of splenic T cells in C57BL\/6 mice. Parasitol. Res. 124, 31 (2025).","journal-title":"Parasitol. Res."},{"issue":"7","key":"55860_CR51","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s43587-024-00642-y","volume":"4","author":"G Katsuumi","year":"2024","unstructured":"Katsuumi, G. et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nat. Aging. 4 (7), 926\u2013938 (2024).","journal-title":"Nat. Aging"},{"issue":"1","key":"55860_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41514-025-00227-y","volume":"11","author":"ZE Yesilyurt-Dirican","year":"2025","unstructured":"Yesilyurt-Dirican, Z. E. et al. SGLT2 inhibitors as a novel senotherapeutic approach. NPJ Aging. 11 (1), 35 (2025).","journal-title":"NPJ Aging"},{"issue":"3","key":"55860_CR53","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cellsig.2008.10.011","volume":"21","author":"JL Ren","year":"2009","unstructured":"Ren, J. L., Pan, J. S., Lu, Y. P., Sun, P. & Han, J. Inflammatory signaling and cellular senescence. Cell. Signal. 21 (3), 378\u2013383 (2009).","journal-title":"Cell. Signal."},{"issue":"Suppl 1","key":"55860_CR54","first-page":"S45","volume":"22","author":"R Singh","year":"2007","unstructured":"Singh, R. & & Czaja, M. J. Regulation of hepatocyte apoptosis by oxidative stress. J. Gastroenterol. Hepatol. 22 (Suppl 1), S45\u2013S48 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"55860_CR55","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/1873-3468.14864","volume":"598","author":"SS Kim","year":"2024","unstructured":"Kim, S. S. & & Seo, S. R. Caspase\u20133 targets pro-interleukin\u20131\u03b2 (IL\u20131\u03b2) to restrict inflammation. FEBS Lett. 598 (11), 1366\u20131374 (2024).","journal-title":"FEBS Lett."},{"issue":"1","key":"55860_CR56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","volume":"9","author":"JL Lu","year":"2023","unstructured":"Lu, J. L., Yu, C. X. & Song, L. J. Programmed cell death in hepatic fibrosis: Current and perspectives. Cell. Death Discov. 9 (1), 449 (2023).","journal-title":"Cell. Death Discov"},{"key":"55860_CR57","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3389\/fimmu.2018.01979","volume":"9","author":"ARR Vicentino","year":"2018","unstructured":"Vicentino, A. R. R. et al. Emerging role of HMGB1 in the pathogenesis of schistosomiasis liver fibrosis. Front. Immunol. 9, 1979 (2018).","journal-title":"Front. Immunol."},{"issue":"10","key":"55860_CR58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20 (10), 633\u2013646 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"55860_CR59","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1007\/s10787-025-01750-w","volume":"33","author":"AA El-Demerdash","year":"2025","unstructured":"El-Demerdash, A. A., Darwish, S. F. & El-Derany, M. O. El-Demerdash, E. Dapagliflozin targets the crosstalk between apoptosis, autophagy, and Hedgehog signaling pathways through AMPK activation in the adjuvant-induced arthritic rat model. Inflammopharmacology 33 (6), 3157\u20133176 (2025).","journal-title":"Inflammopharmacology"},{"issue":"1","key":"55860_CR60","first-page":"655","volume":"47","author":"SMM Elkhyat","year":"2024","unstructured":"Elkhyat, S. M. M., Elmahdy, N. A., Elhusseiny, M. E. & Zidan, A. A. Impact of dapagliflozin on apoptosis and effector cytotoxic cells using breast cancer cells in mice. Bull. Pharm. Sci. Assiut Univ. 47 (1), 655\u2013667 (2024).","journal-title":"Bull. Pharm. Sci. Assiut Univ."},{"issue":"5","key":"55860_CR61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3892\/ol.2022.13521","volume":"24","author":"JH Jang","year":"2022","unstructured":"Jang, J. H., Lee, T. J., Sung, E. G., Song, I. H. & Kim, J. Y. Dapagliflozin induces apoptosis by downregulating cFILPL and increasing cFILPS instability in Caki\u20131 cells. Oncol. Lett. 24 (5), 401 (2022).","journal-title":"Oncol. Lett."},{"issue":"2","key":"55860_CR62","doi-asserted-by":"publisher","first-page":"97287","DOI":"10.4239\/wjd.v16.i2.97287","volume":"16","author":"SX Xiong","year":"2025","unstructured":"Xiong, S. X. et al. Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase\/protein kinase B signaling pathway. World J. Diabetes. 16 (2), 97287 (2025).","journal-title":"World J. Diabetes"},{"issue":"8","key":"55860_CR63","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1078\/0171-9335-00182","volume":"80","author":"B Saile","year":"2001","unstructured":"Saile, B., Matthes, N., Armouche, E., Neubauer, H., Ramadori, G. & K. & The bcl, NF-kappaB and p53\/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur. J. Cell. Biol. 80 (8), 554\u2013561 (2001).","journal-title":"Eur. J. Cell. Biol."},{"issue":"5","key":"55860_CR64","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0002-9440(10)63544-4","volume":"163","author":"F Oakley","year":"2003","unstructured":"Oakley, F. et al. Hepatocytes express nerve growth factor during liver injury: Evidence for paracrine regulation of hepatic stellate cell apoptosis. Am. J. Pathol. 163 (5), 1849\u20131858 (2003).","journal-title":"Am. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55860-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:02:51Z","timestamp":1780743771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55860"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55860-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent to publish"}},{"value":"All animal procedures followed the ethical principles, guidelines, and regulations of the Mansoura University Animal Care and Use Committee (MU-ACUC); code number: MU-ACUC (MED.R.25.01.54), in compliance with the ARRIVE guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17537"}}